Abstract
Typical therapies try to reverse pathogenic mechanisms. Here, we describe treatment effects by enhancing depression-causing mechanisms in ventral tegmental area (VTA) dopamine (DA) neurons. In a social defeat stress model of depression, depressed (susceptible) mice display hyperactivity of VTA DA neurons, caused by an up-regulated hyperpolarization-activated current (Ih). Mice resilient to social defeat stress, however, exhibit stable normal firing of these neurons. Unexpectedly, resilient mice had an even larger Ih, which was observed in parallel with increased potassium (K+) channel currents. Experimentally enhancing the firing-increasing Ih or optogenetically increasing the hyperactivity of VTA DA neurons in susceptible mice, completely reversed depression-related behaviors, an antidepressant effect achieved through resilience-like, projection-specific homeostatic plasticity. These results indicate a potential therapeutic path of promoting natural resilience for depression treatment.
Resilience is the brain’s capacity to cope with environmental stress and achieve stable psychological functioning in response to prolonged stress (1–3). Multiple psychological techniques are used to promote resilience to stress. Specifically, active coping strategies, in which qualities or perceptions of stressors are reassessed, as opposed to avoidant coping, have proven to promote behavioral adaptability and achieve psychological resilience (4, 5). To understand the neurobiological mechanisms underlying stress resilience, tremendous efforts have been made to investigate the genetic, molecular and developmental aspects of this phenomenon (1, 3, 6, 7). Despite many advances, the neurophysiological processes determining the brain’s ability to cope with stress are still poorly understood.
Multiple lines of evidence implicate dysregulation in the brain’s reward neural circuit in depression (1, 8–11). In a well-established chronic social defeat model of depression, susceptible and resilient phenotypes have been successfully segregated following a 10-day social defeat paradigm (1, 9, 12, 13). Multiple depressive symptoms in susceptible mice have been causally linked to hyperactivity of ventral tegmental area (VTA) dopamine (DA) neurons (1, 9, 12). Optogenetic activation of these neurons promotes susceptible phenotype, whereas optogenetic reduction of the hyperactivity reverses depression-related behaviors (9). This increase in VTA DA neuron firing in susceptible mice is known to be intrinsically induced by up-regulation of hyperpolarization-activated cation channel-mediated current (Ih), an excitatory driving force in VTA DA neurons (12, 14, 15). Pharmacological reduction of the increased Ih in susceptible mice reverses depression-related symptoms (12). Chronic antidepressant fluoxetine treatment normalizes the hyperactivity and decreases Ih in these neurons (12). These observations suggest that hyperactivity and increased excitatory Ih in VTA DA neurons are both pathophysiological adaptations underlying the susceptible phenotype.
To understand the neurophysiological mechanisms of the resilient phenotype following chronic social stress, we employed tyrosine-hydroxylase (TH)-GFP mice to visualize and reliably record from VTA DA neurons (fig. S1A). TH-GFP mice that undergo chronic social defeat stress reliably separate into either susceptible or resilient phenotypes based on social interaction ratios (fig. S1, B and C) (1, 9, 12, 13). Susceptible TH-GFP mice showed social avoidance, spending significantly less time in the interaction zone, while resilient mice spent a significant amount of time with the social target, similar to that of control mice (fig. S1, D to G). Susceptible mice also display other depression-related anhedonic behaviors (fig. S1H) (1, 7). We confirmed pathophysiological hyperactivity in the GFP-visualized DA neurons of susceptible TH-GFP mice (fig. S1I), while the pacemaker firing pattern was the same in the three groups. Overall, the resilient TH-GFP mice exhibited a stable control level firing of VTA DA neurons, appearing not to have undergone any pathogenic changes at cellular and behavioral levels in response to chronic social defeat stress (fig. S1, D to I and fig. S2).
We next investigated if the pathophysiological increase in Ih current is normalized in resilient mice. We performed whole-cell voltage-clamp recordings in GFP+ VTA DA neurons in brain slices from control, susceptible and resilient TH-GFP mice. In accordance with previous findings (12), Ih was increased in susceptible mice (Fig. 1A). However, unexpectedly, rather than a normalization of the Ih levels in resilient mice, the resilient phenotype showed an even larger significant increase in Ih when compared to susceptible and control mice (Fig. 1A). This was surprising and unanticipated because this firing-increasing Ih was viewed as a stress-induced, pathological ion mechanism in susceptible mice.
To understand how VTA DA neurons in resilient mice maintain a level of firing similar to control mice with this extremely larger Ih, we focused on K+ channels, an inhibitory driving force that was up-regulated selectively in the resilient subgroup in a previous microarray analysis (1). The VTA DA neurons of resilient mice, which displayed a further enhanced Ih, simultaneously exhibited significantly increased K+ channel-mediated peak and sustained currents (Fig. 1B), implicating multiple K+ channel types mediating this increase in K+ currents.
To investigate a possible benefit of resilient mice recruiting these extra channel functions, we measured intrinsic excitabilities of VTA DA neurons in the three groups. In response to a series of current injections, we observed an increase in spike number in susceptible mice, and inversely, a reduction in spike number in resilient mice, as compared to control mice (Fig. 1C). This suggests that the re-established status of VTA DA neurons in resilient mice is more stable and less vulnerable to perturbations than that of control.
The up-regulation of Ih in VTA DA neurons of resilient mice may be driving the neuronal firing extremely high and triggering a self-tuning K+ current mechanism to bring the extreme firing back to control (fig. S3). This in turn normalizes the depressive behaviors. To determine whether enhancing Ih current in susceptible mice can trigger this hypothesized homeostatic plasticity observed in the resilient mice, we pharmacologically increased Ih through in vivo infusion of an Ih potentiator, lamotrigine, into the VTA of TH-GFP susceptible mice. Lamotrigine is known to enhance Ih (16) and is clinically used as a mood stabilizer to treat the depressed phase of bipolar disorder with uncertain mechanisms (17). In brain slices, bath application of lamotrigine increased Ih and the firing rate of VTA DA neurons (fig. S4). Consistently, a single in vivo infusion into the VTA of susceptible mice increased social avoidance (fig. S5). To determine if repeated enhancement of this current can induce a homeostatic compensatory response, we performed repeated 5 day local infusions of lamotrigine (0.1 μg) into the VTA of susceptible TH-GFP mice because it is known that 4–5 days is sufficient to induce stable changes in social behaviors (Fig. 1, D and E, and fig. S6A) (18). After 5 days of local infusion, we observed a profound reversal of social avoidance, with more time spent interacting with a social target (Fig. 1F) and reduced time in the corner zone (fig. S6B), without adverse effects on locomotion (fig. S6C). The defeat-induced deficit in sucrose preference was also significantly reversed following repeated lamotrigine infusion (Fig. 1G), indicating an overall resilient, antidepressant effect, without affecting the behaviors in either control or resilient mice (fig. S7 and S8).
Consistent with the behavioral antidepressant effect, the hyperactivity of VTA DA neurons in susceptible mice was normalized following Ih potentiation via lamotrigine (Fig. 1H). To examine the ionic mechanisms that underlie this promotion of resilience, we determined the effects of repeated lamotrigine infusion on Ih and K+ currents. We observed a marked increase in Ih (Fig. 1I) and a compensatory increase in K+ currents (Fig. 1J), a phenomenon not observed at lower doses (fig. S9). Consistently, these ionic changes induced a reduction in DA neuron excitability in the lamotrigine treated animals (Fig. 1K) as compared to vehicle control. These data describe a possible mechanism of lamotrigine’s mood stabilizing efficacy.
While one of the actions of lamotrigine is known to increase Ih current, lamotrigine has other effects on neurons such as blockade of sodium channels (19). To specifically assess the role enhanced Ih has in VTA DA neurons, we selectively over-expressed hyperpolarization-activated and cyclic nucleotide-gated channel 2 (HCN2), a channel isoform which mediates Ih current (20). We used a combination of TH-Cre mice and Cre-inducible loxP-STOP-loxP herpes simplex virus (HSV-LS1L-HCN2-eYFP), and HSV-LS1L-eYFP as control. The HSV vectors allow for the rapid expression of HCN2 over 5 days (18). The Cre-inducible vectors were injected bilaterally into the VTA of TH-Cre transgenic mice to ensure specific expression in DA neurons (Fig. 2, A and B). Functional validation 24 hours post injection successfully showed an increase in Ih (Fig. 2C) and corresponding increase in firing (Fig. 2D). Next, we injected HSV-LS1L-HCN2-eYFP or HSV-LS1L-eYFP into the VTA of susceptible TH-Cre mice and carried out the behavioral and electrophysiological measurements 4–6 days after viral injection (Fig. 2, E and F). Over-expression of HCN2 in the VTA DA neurons of susceptible mice resulted in a reversal of social avoidance (Fig. 2G and fig. S10A) and other depressive behaviors (Fig. 2, H and I) with no affect on locomotion (fig. S10B).
Following DA neuron-specific expression of HCN2 in susceptible mice, a robust reduction in hyperactivity was found in HCN2 expressing DA neurons, as compared to eYFP control (Fig. 2J). We observed a significant increase in Ih current in HCN2-expressing cells (Fig. 2K) and in conjunction, we observed a significant increase in the K+ currents (Fig. 2L), resulting in an overall reduction in excitability of these neurons (Fig. 2M).
While excessively potentiating Ih resulted in a homeostatic up-regulation of K+ channel function in VTA DA neurons of susceptible mice, this K+ current compensation may be caused directly by the hyperactivity induced by Ih potentiation. In primary neuronal cultures excessive hyperactivity can induce homeostatic up-regulation of K+ channel-mediated current (21). We thus asked whether direct excessive activation of VTA DA neurons in susceptible mice could induce a functional K+ channel counteraction that would normalize the hyperactivity of these neurons and depression-related behaviors. We examined social interaction behaviors and the channel functions following repeated optogenetic activation of VTA DA neurons in susceptible mice – further increasing the hyperactivity in susceptible mice. We injected Cre-inducible adenovirus-associated channelrhodopsin-2 (AAV-DIO-ChR2-eYFP) or control vector (AAV-DIO-eYFP) into the VTA of susceptible TH-Cre mice to selectively express ChR2 in VTA DA neurons (Fig. 3, A to C) (9, 22, 23). Bilateral implantable optic fibers were placed above the VTA (fig. S11A) for blue light photo-stimulation (5 pulses, 20 Hz/10 sec period; Fig. 3, D and E) of DA neurons in susceptible mice, mimicking a validated in vivo firing pattern (9, 12, 23, 24). After 5 days of 20 min photo-stimulation, susceptible mice with viral expression of ChR2 showed reduced social avoidance, (Fig. 3F and fig. S11B) and reduced depressive behaviors (Fig. 3, G and H), without adverse effects on locomotion (fig. S11C). Excessive optogenetic activation of VTA DA neurons in susceptible mice reduced firing rate (Fig. 3I) and increased K+ currents (Fig. 3J) in the ChR2-infected neurons, without altering Ih (fig. S11D). Consistent with the ionic alterations, we found a reduction in excitability of the ChR2-infected neurons (Fig. 3K).
Recent studies show that VTA DA neurons are heterogeneous (9, 11, 25, 26). For instance, VTA DA neurons projecting to nucleus accumbens (NAc) exhibit a large Ih, while medial prefrontal cortex (mPFC)-projecting VTA DA neurons have a small Ih (26). Utilizing retrograde tracers, we found that Ih alterations in response to chronic social defeat occur specifically in NAc-projecting VTA neurons, but not in mPFC-projecting VTA neurons (Fig. 4A and 4H, and fig. S12A and S13A). Interestingly, the homeostatic plasticity that occurs in response to projection-specific HCN2 over-expression and repeated optogenetic stimulation is unique to the VTA-NAc projection (Fig. 4, B to G, and fig. S12). A different form of plasticity occurred in VTA-mPFC neurons: surprisingly, HCN2 over-expression had no effects on behavior, firing, Ih, and K+ currents (Fig. 4, I to K, and fig. S13, B to G), whereas repeated optogenetic stimulation reversed social avoidance accompanied by a firing increase and a K+ current decrease, the physiological changes opposite to what were seen in VTA-NAc neurons (Fig. 4, L to N, and fig. S13, H to L).
Self-tuning adaptation of neuronal activity as a homeostatic plasticity concept was first described in primary neuronal culture (27) and further observed in in vivo animal models (28, 29). Evidence demonstrates that homeostatic plasticity plays a fundamental role in stabilizing neuronal activity in response to excessive perturbations under both physiological (30, 31) and disease (32) conditions. We observed that resilient mice displayed enhanced Ih current in VTA DA neurons, and simultaneously exhibited up-regulated inhibitory K+ currents. Based on this unexpected observation, we tested the hypothesis that the resilience phenotype achieves its stable behavioral functioning through homeostatic plasticity and that this homeostatic adaptation can be established therapeutically in susceptible mice. Utilizing pharmacological, viral and optogenetic approaches, we found that enhancement of Ih or excessive activation of VTA DA neurons triggered self-tuning compensation of K+ currents and functionally normalized the firing of these hyperactive neurons in susceptible animals, a homeostatic plasticity seen in VTA-NAc projection, but not in VTA-mPFC pathway. Once the homeostatic balance is established naturally or experimentally in VTA DA neurons, these neurons are more stable as indicated by their reduced response to physiological perturbation. Our findings advance the understanding of homeostatic plasticity in a behaviorally relevant in vivo disease model of depression and provide further insight into the stabilized physiological underpinnings of natural resilience.
While homeostatic plasticity describes much of our current findings, the counterintuitive process by which ionic, cellular and behavioral alterations are achieved and its close similarity to natural stress-resilience remains surprising. Recently, cell type-specific and neural circuit-probing optogenetic approaches has assisted in unraveling multiple unforeseen functions of the brain’s reward DA neurons (9, 11, 22, 23, 26, 33). By revealing a previously uncharacterized ionic mechanism of intrinsic homeostatic plasticity we are bringing new insight to the complex functions of these neurons. Notably, the experimentally induced homeostatic plasticity in VTA-NAc projecting neurons is triggered by enhancing stress-activated Ih current and stress-induced neuronal hyperactivity. Therefore, rather than reversing the underlying disruption or pathological mechanisms the stress-activated pathogenic changes can be beneficially used to achieve treatment efficacy (fig. S14). Interestingly, reversing pathological adaptations rapidly induces antidepressant effects (9, 11), while chronic manipulations are needed to promote active resilient mechanisms and achieve treatment efficacy. Overall, our findings not only unravel a critical self-stabilizing capacity of midbrain DA neurons in the brain’s reward circuit, but also identify a conceptually different therapeutic strategy of promoting natural resilience. This may provide useful information for the development of naturally acting antidepressants.
Supplementary Material
Acknowledgments
We thank E.J. Nestler for his continuing support of this work. We also thank S.J. Russo, H.P. Xu, J.L. Cao, F. Henn, and E.J. Nestler for their helpful discussion. We are grateful to G.R. Tibbs and P.A. Goldstein from Weill Cornell Medical College for providing the HCN2 plasmid. This work was supported by the National Institute of Mental Health (R01 MH092306: S.M.K., D.C., M.H.H.), National Research Service Award (F31 MH095425: J.J.W.; T32 MH 087004: B.J.; F32 MH096464: A.K.F.), and Johnson & Johnson/IMHRO Rising Star Translational Research Award (M.H.H.).
References and Notes
- 1.Krishnan V, et al. Cell. 2007;131:391. doi: 10.1016/j.cell.2007.09.018. [DOI] [PubMed] [Google Scholar]
- 2.Feder A, Nestler EJ, Charney DS. Nat Rev Neurosci. 2009;10:446. doi: 10.1038/nrn2649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Russo SJ, Murrough JW, Han MH, Charney DS, Nestler EJ. Nat Neurosci. 2012;15:1475. doi: 10.1038/nn.3234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kumar S, Feldman G, Hayes A. Cognitive Therapy and Research. 2008;32:734. doi: 10.1007/s10608-006-9083-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Carey TA. Clinical Psychology Review. 2011;31:236. doi: 10.1016/j.cpr.2010.04.004. [DOI] [PubMed] [Google Scholar]
- 6.Southwick SM, Charney DS. Science. 2012;338:79. doi: 10.1126/science.1222942. [DOI] [PubMed] [Google Scholar]
- 7.Vialou V, et al. Nat Neurosci. 2010;13:745. doi: 10.1038/nn.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nestler EJ, Carlezon WA., Jr Biol Psychiatry. 2006;59:1151. doi: 10.1016/j.biopsych.2005.09.018. [DOI] [PubMed] [Google Scholar]
- 9.Chaudhury D, et al. Nature. 2012 [Google Scholar]
- 10.Berton O, et al. Science. 2006;311:864. doi: 10.1126/science.1120972. [DOI] [PubMed] [Google Scholar]
- 11.Tye KM, et al. Nature. 2013;493:537. doi: 10.1038/nature11740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Cao JL, et al. The Journal of Neuroscience. 2010;30:16453. doi: 10.1523/JNEUROSCI.3177-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Golden SA, Covington HE, Berton O, Russo SJ. Nat Protocols. 2011;6:1183. doi: 10.1038/nprot.2011.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wanat MJ, Hopf FW, Stuber GD, Phillips PEM, Bonci A. The Journal of Physiology. 2008;586:2157. doi: 10.1113/jphysiol.2007.150078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Neuhoff H, Neu A, Liss B, Roeper J. J Neurosci. 2002;22:1290. doi: 10.1523/JNEUROSCI.22-04-01290.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Poolos NP, Migliore M, Johnston D. Nat Neurosci. 2002;5:767. doi: 10.1038/nn891. [DOI] [PubMed] [Google Scholar]
- 17.Frye MA. New England Journal of Medicine. 2011;364:51. doi: 10.1056/NEJMcp1000402. [DOI] [PubMed] [Google Scholar]
- 18.Wilkinson MB, et al. The Journal of Neuroscience. 2011;31:9084. doi: 10.1523/JNEUROSCI.0039-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Nakatani Y, Masuko H, Amano T. Journal of Pharmacological Sciences. 2013;123:203. doi: 10.1254/jphs.13116sc. [DOI] [PubMed] [Google Scholar]
- 20.Biel M, Wahl-Schott C, Michalakis S, Zong X. Physiol Rev. 2009;89:847. doi: 10.1152/physrev.00029.2008. [DOI] [PubMed] [Google Scholar]
- 21.Zhang J, Shapiro MS. Neuron. 2012;76:1133. doi: 10.1016/j.neuron.2012.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Tsai HC, et al. Science. 2009;324:1080. doi: 10.1126/science.1168878. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Walsh JJ, et al. Nature Neuroscience. 2014;17:27. doi: 10.1038/nn.3591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Koo JW, et al. Science. 2012;338:124. doi: 10.1126/science.1222265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL. J Neurosci. 2008;28:8908. doi: 10.1523/JNEUROSCI.1526-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Lammel S, et al. Neuron. 2008;57:760. doi: 10.1016/j.neuron.2008.01.022. [DOI] [PubMed] [Google Scholar]
- 27.Turrigiano G, Abbott LF, Marder E. Science. 1994;264:974. doi: 10.1126/science.8178157. [DOI] [PubMed] [Google Scholar]
- 28.Turrigiano G. Annu Rev Neurosci. 2011;34:89. doi: 10.1146/annurev-neuro-060909-153238. [DOI] [PubMed] [Google Scholar]
- 29.Maffei A, Nataraj K, Nelson SB, Turrigiano GG. Nature. 2006;443:81. doi: 10.1038/nature05079. [DOI] [PubMed] [Google Scholar]
- 30.Destexhe A, Marder E. Nature. 2004;431:789. doi: 10.1038/nature03011. [DOI] [PubMed] [Google Scholar]
- 31.Whalley K. Nat Rev Neurosci. 2013;14:820. doi: 10.1038/nrn3637. [DOI] [PubMed] [Google Scholar]
- 32.Dickman DK, Davis GW. Science. 2009;326:1127. doi: 10.1126/science.1179685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lammel S, et al. Nature. 2013;491:212. doi: 10.1038/nature11527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wallace DL, et al. Nat Neurosci. 2009;12:200. doi: 10.1038/nn.2257. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.